Experts consensus on Chinese nomenclature of Budd-Chiari syndrome
Maoheng Zu(Xuzhou Medical College), Zu Maoheng(Xuzhou Medical College), Ce Bian(Sichuan University), Kai Xü, Chenghao Guo(Shandong University), Ni Caifang, Liu Zuo-qin, Yanhao Li(Xinjiang Production and Construction Corps), Hao Xu(Anhui University), Zhonggao Wang(Capital Medical University), Yan Zhiping(Southern Medical University), Zhen Li(Tongji Hospital), Ke Xu(Shanxi Medical University), Cao Jianmin(Chinese People's Liberation Army), Wei Mu(Tongji Hospital), Han Xinwei(First Affiliated Hospital of Zhengzhou University), Gao Yong(Bengbu Medical College), Jiahong Dong(Beijing Tsinghua Chang Gung Hospital), Zhang Lin(Nanjing Medical University), Jianping Gu(Nanjing Medical University), Wang Maoqiang, Jinguo Cui(Chinese People’s Liberation Army 263 hospital), Li Linsun, Gu Yuming(Xuzhou Medical College), Hua Xiang(Qinghai Tibetan Hospital)
Cited by 1
Related Papers
Cancer drug delivery in the nano era: An overview and perspectives
|Oncology Reports|2017|399
IL-10 Suppresses Chemokines, Inflammation, and Fibrosis in a Model of Chronic Renal Disease
|Journal of the American Society of Nephrology|2005|154
T regulatory cell function in idiopathic minimal lesion nephrotic syndrome
|Pediatric Nephrology|2009|140
In Vivo Administration of a Nuclear Transcription Factor-κB Decoy Suppresses Experimental Crescentic Glomerulonephritis
|Journal of the American Society of Nephrology|2000|114